Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > House Positions for C:SZLS for yesterday and today
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(131)
•••
Comment by gojotv!on Jul 08, 2021 1:57am
135 Views
Post# 33510576

RE:RE:RE:RE:RE:House Positions for C:SZLS for yesterday and today

RE:RE:RE:RE:RE:House Positions for C:SZLS for yesterday and todayPoor dum-dum! $45K may seem like nothing, but the 100,000 shares represent more that 1% of SZLS...
A group like Cormack can't just step in and start pwning all the shares, or they'll cause a run and takeover speculation.
At this stage, it's wise for them to have SZLS in their portfolio with a good, small chunk, so they can move quickly when anything happens.

Liked2Think wrote: haha only you could take me asking why doesnt stagezero be bought out for 1/4 that of which Illumia is trying to buy back grail as people saying Stagezero is worth 2 Billion.

you have to be on crack there is no other explanation 

And if cormark buying $45K worth of this stock is something big to talk about then I am more worried now than ever because I know how much I have sunk into this play. $45K to them is nothing. 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities